Federal Circuit’s Ruling on USPTO’s Request Highlights Ongoing Debates Over Patent Adjudication Fairness

The Federal Circuit has recently granted a request by the acting head of the United States Patent and Trademark Office (USPTO) to revise a contentious decision by the Patent Trial and Appeal Board (PTAB) involving Longhorn Vaccines & Diagnostics. The original PTAB ruling had annulled 183 patent claims held by Longhorn, citing an “egregious abuse of the PTAB process” as the basis for its decision. This development allows for the possibility that a portion or all of these patent claims could be reinstated following the revision process. The acting USPTO head’s successful bid underscores ongoing debates about procedural fairness and enforcement within the patent adjudication system. For further details, access the original article here.